Typicality: | 0.384 |
Saliency: | 0.315 |
for neurodegenerative diseases | 6 | transitive-object |
for the myoc-associated poag | 3 | transitive-object |
to eliminate the mutant myocilin proteins | 2 | purpose |
gene → silence → therapy | 26 |
negative | neutral | positive |
0.118 | 0.748 | 0.134 |
Raw frequency | 26 |
Normalized frequency | 0.315 |
Modifier score | 0.500 |
Perplexity | 43.927 |